Matthew Wolfson serves as Executive at Electromedical Technologies, Inc, where they oversee executive responsibilities. Since joining the company, Matthew Wolfson has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 17, 2021 involved receiving (via award) 1,100,000 shares valued at $594.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 17, 2021 | EMED | $594.0K | Award | 1,100,000 | $0.54 | Discretionary |
Matthew Wolfson currently holds 15,306,250 shares of Electromedical Technologies, Inc (EMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Wolfson has been a net neutral trader of EMED stock. They have purchased $0 and sold $0 worth of shares.
Matthew Wolfson's most recent insider trade was on Feb 17, 2021, when they sold 1,100,000 shares at $0.54 per share.
Get notified when new Form 4 filings are submitted